September 2020
ReportsEdge added a report on global rapid microbiology testing market which includes study on method, product, application, end user across various countries of key regions across the globe. The global rapid microbiology testing market was projected to grow at a CAGR of 10.73% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the rapid microbiology testing market.
The report analyses the global rapid microbiology testing industry based on method, product, application, end user and geography. Various method studied in the report are growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing & other rapid microbiology testing methods. The products of the industry are classified into instruments, reagents & kits & consumables. Furthermore, several applications of the industry are segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, environmental testing, cosmetics & personal care products testing and research applications and other applications. The end users of rapid microbiology testing industry are diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical & biotechnology companies, contract research organizations, and other end users. The global rapid microbiology testing market is studied across various key countries of regions such as, North America, Europe, Asia Pacific and Rest of the World.
Major Players in Rapid Microbiology Testing Market
The key competitors of this market include bioMérieux SA (France). Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Don Whitley Scientific Limited (UK), Merck KGaA (Germany), Neogen (US), Quidel Corporation (US), Rapid Micro Biosystems, Inc. (US), Sartorius Group (Germany), Thermo Fisher Scientific (US), TSI Inc. (US), and Vivione Biosciences, LLC (US).
Covid-19 Impact Analysis on Rapid Microbiology Testing Market
The global pandemic of Coronavirus (COVID-19) has triggered stock market unpredictability, tight border controls, and worldwide lockdown, leading the aesthetic industry, as well as large companies and governments, to restock supply chains. The whole world is experiencing severe impact on social and financial sectors, and all global industries are facing challenges during the COVID-19 pandemic. The exclusive COVID-19 Impact Analysis report by ReportsEdge explores the outbreak of COVID-19, its impact on the global and regional economies, and its implications on the cosmetic sector. The report studies the effect of the pandemic on the global economy by evaluating factors like consumption, GDP, business investment, key players marketing strategies, key supply and demand-side factors, epidemiological swing factors, inventory, and governmental policies & decisions.
Rapid Microbiology Testing Market Regional Analysis
The North America accounted for the largest market share in 2019 in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America.
Rapid Microbiology Testing Market Segmental Highlights
- The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period, due to the increasing use of rapid microbiology testing for the diagnosis of infectious diseases in humans; rising emphasis on effective and early disease diagnosis across major markets; and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis
- Among the various methods employed in the rapid microbiology testing, the growth-based rapid microbiology testing segment is anticipated dominate the market in 2019, due to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations
- In 2019, diagnostic laboratories & hospitals accounted for the major market share in terms of revenue, due to flooding demand from critically ill patients and high occurrence of infectious disease and increasing geriatric populace
